A five-year-old boy with underlying illnesses remains in intensive care in serious condition after an influenza A infection complicated by severe pneumonia, Hong Kong's Centre for Health Protection said on September 1.
The UK Government has tabled three Health Bill amendments covering MHRA information sharing, updates to medicines and medical devices legislation, and enabling powers for a future medical device licensing regime. According to the MHRA on 1 September 2026, no immediate changes to regulation follow.
The Department of Health says the WT1 vaccine is not registered in Hong Kong, and it is taking enforcement action against medical centres reported to be offering it with claims of preventing multiple cancers.
Hong Kong's Centre for Health Protection said its 2026/27 seasonal influenza vaccination programmes, including school outreach, care home vaccination and a subsidy scheme, were scheduled to start on September 17, with flu activity still high.
Annual UKHSA data for 2025 to March 2026 show signs that uptake by age five is stabilising after a decade of slow decline in England, yet rates remain below the WHO 95% target and fell again at ages one and two.
An MHRA review reported on 26 August 2026 found increased risks of wear and corrosion with certain cobalt-chrome modular neck hip replacements, affecting an estimated 750 UK patients, and advised NHS trusts to invite them for clinical review.
The Department for Work and Pensions named Professor David Strain its new Chief Medical Advisor in a release dated 26 August 2026, with the University of Exeter and NHS clinician due to start from the end of that month.
Hong Kong's Health Bureau and the operator of The Chinese Medicine Hospital of Hong Kong announced an expansion plan on August 25, including planned 24-hour inpatient services from December 11 and 10 additional special disease programmes by year end.
A 35-year-old woman is Hong Kong's ninth measles case this year, the Centre for Health Protection said on August 18, 2026. Close contacts are under medical surveillance and all are asymptomatic so far.
As of 18 August 2026, no microbiome-based medicinal product held a UK marketing authorisation, the MHRA said. Some countries have authorised a small number of donor-derived microbiota products for C. difficile infection.
As of 17 August 2026, the DVLA said car and motorcycle licence holders could report a wider range of medical conditions online, with some applications processed up to 10 days faster than paper ones.
On 14 August 2026, the UK Chief Veterinary Officer urged livestock keepers to watch for bluetongue and consider vaccination, with cases rising in parts of Great Britain.
WeeklyTrail